Government

Image description

Meningococcal vaccine Bexsero gets FDA approval

The Food and Drug Administration last week announced approval for Bexsero, a vaccine intended to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 years through 25 years of age.

 

Image description

CVS Health gets special SOTUS shout-out from Obama

Not only was CVS Health president and CEO Larry Merlo a special guest of First Lady Michelle Obama for Tuesday night’s Presidential State of the Union address, but Merlo was also treated to a special shout out from the President.

 

Image description

FDA approves Consentyx from Novartis

The Food and Drug Administration on Wednesday announced approval for Cosentyx (secukinumab), indicated for the treatment of adults with moderate to severe plaque psoriasis.

 

Image description

Rx trends 2015: Managing the newly insured

If its goal of expanding health coverage to more Americans is fully realized, the Affordable Care Act could end up pulling as many as 30 million more people into the ranks of the newly insured. That means rising prescription counts and more patients at pharmacy counters and in drug store aisles, but it also poses challenges in managing and educating patients about their benefits.

 

Image description

Supreme Court ruling protects Teva's Copaxone patent

Teva Pharmaceutical on Tuesday announced the U.S. Supreme Court’s decision in Teva Pharmaceuticals USA vs. Sandoz et al. that reversed the Federal Circuit Court’s judgment of invalidity of Teva’s ‘808 patent for Copaxone (glatiramer acetate injection) 20 mg/mL.

Image description

FDA approves AbbVie's Duopa

AbbVie announced that the Food and Drug Administration has approved its Duopa (carbidopa and levodopa) enteral suspension, which is used to treat motor fluctuations for people with advanced Parkinson's disease.